Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-22-006657

EVP, Corp Strategy & Develop sold 395 shares at $292.75 ($115,636)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2022-02-23 Sale −395 $292.75 $115,636 19,852 D
Open-market sales · 395 sh · avg $292.75 · $115,636
Loading xslF345X03/form4.xml…